Have a feature idea you'd love to see implemented?
Let us know!
AHCO AdaptHealth Corp
Price (delayed)
$10.28
Market cap
$1.38B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.64
Enterprise value
$3.46B
AdaptHealth is a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States. AdaptHealth provides a full suite of medical products and
Highlights
The net income has soared by 69% from the previous quarter and by 50% YoY
The EPS has surged by 68% since the previous quarter and by 48% year-on-year
AHCO's equity is down by 12% year-on-year but it is up by 2% since the previous quarter
AHCO's quick ratio is up by 7% since the previous quarter but it is down by 4.2% year-on-year
Key stats
What are the main financial stats of AHCO
Market
Valuations
Earnings
Shares outstanding
134.55M
Market cap
$1.38B
Enterprise value
$3.46B
Price to book (P/B)
0.91
Price to sales (P/S)
0.42
EV/EBIT
N/A
EV/EBITDA
10.57
EV/Sales
1.06
Revenue
$3.26B
Gross profit
$527.7M
Net income
-$214.34M
EBIT
-$80.1M
EBITDA
$327.57M
Free cash flow
$234.64M
Per share
Balance sheet
Liquidity
EPS
-$1.64
EPS diluted
-$1.68
Free cash flow per share
$1.75
Book value per share
$11.28
Revenue per share
$24.29
TBVPS
$12.28
Total assets
$4.47B
Total liabilities
$2.95B
Debt
$2.18B
Equity
$1.52B
Working capital
$130.77M
Debt to equity
1.44
Current ratio
1.24
Quick ratio
0.91
Net debt/EBITDA
6.35
Margins
Efficiency
Dividend
EBITDA margin
10%
Gross margin
16.2%
Net margin
-6.6%
Operating margin
-1.6%
Return on assets
-4.8%
Return on equity
-14.5%
Return on invested capital
-2.4%
Return on capital employed
-2%
Return on sales
-2.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AHCO stock price
How has the AdaptHealth stock price performed over time
Intraday
6.09%
1 week
7.64%
1 month
5.76%
1 year
58.4%
YTD
41.02%
QTD
-8.46%
Financial performance
How have AdaptHealth's revenue and profit performed over time
Revenue
$3.26B
Gross profit
$527.7M
Operating income
-$51.74M
Net income
-$214.34M
Gross margin
16.2%
Net margin
-6.6%
AdaptHealth's operating margin has surged by 91% QoQ and by 86% YoY
AHCO's operating income has surged by 91% since the previous quarter and by 85% year-on-year
The net income has soared by 69% from the previous quarter and by 50% YoY
The net margin has soared by 69% since the previous quarter and by 52% year-on-year
Growth
What is AdaptHealth's growth rate over time
Valuation
What is AdaptHealth stock price valuation
P/E
N/A
P/B
0.91
P/S
0.42
EV/EBIT
N/A
EV/EBITDA
10.57
EV/Sales
1.06
The EPS has surged by 68% since the previous quarter and by 48% year-on-year
AHCO's P/B is 90% lower than its 5-year quarterly average of 9.5
AHCO's equity is down by 12% year-on-year but it is up by 2% since the previous quarter
The stock's price to sales (P/S) is 58% less than its 5-year quarterly average of 1.0 but 5% more than its last 4 quarters average of 0.4
AHCO's revenue is up by 4.5% year-on-year
Efficiency
How efficient is AdaptHealth business performance
The company's return on invested capital has surged by 87% QoQ and by 76% YoY
The return on sales has surged by 86% since the previous quarter and by 76% year-on-year
The ROA has soared by 68% QoQ and by 43% YoY
The company's return on equity has surged by 68% QoQ and by 30% YoY
Dividends
What is AHCO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AHCO.
Financial health
How did AdaptHealth financials performed over time
The total assets is 52% more than the total liabilities
The current ratio has increased by 8% since the previous quarter but it has declined by 5% year-on-year
AHCO's quick ratio is up by 7% since the previous quarter but it is down by 4.2% year-on-year
The debt is 44% greater than the equity
AHCO's equity is down by 12% year-on-year but it is up by 2% since the previous quarter
AHCO's debt to equity is up by 8% year-on-year but it is down by 4% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.